51. Lee YJ, Kusuhara H, Jonker JW, Schinkel AH, Sugiyama Y (2005) Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein. J Pharmacol Exp Ther 312: 44–52. 52. Soontornmalai A, Vlaming ML, Fritschy JM (2006) Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier. Neuroscience 138: 159–169. 53. Shruster A, Eldar-Finkelman H, Melamed E, Offen D (2011) Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid beta-peptide. J Neurochem 116: 522–529. 54. Becker KF, Allmeier H, Hollt V (1992) New mechanisms of hormone secretion: MDR-like gene products as extrusion pumps for hormones? Horm Metab Res 24: 210–213. 55. Korte SM (2001) Corticosteroids in relation to fear, anxiety and psychopathol- ogy. Neurosci Biobehav Rev 25: 117–142. 56. Snyder JS, Hong NS, McDonald RJ, Wojtowicz JM (2005) A role for adult neurogenesis in spatial long-term memory. Neuroscience 130: 843–852. 57. Errijgers V, Van Dam D, Gantois I, Van Ginneken CJ, Grossman AW, et al. (2007) FVB.129P2-Pde6b(+) Tyr(c-ch)/Ant, a sighted variant of the FVB/N mouse strain suitable for behavioral analysis. Genes Brain Behav 6: 552–557. 58. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, et al. (1997) Behavioral phenotypes of inbred mouse strains: implications and recommenda- tions for molecular studies. Psychopharmacology (Berl) 132: 107–124. 59. Krupa DJ, Matell MS, Brisben AJ, Oliveira LM, Nicolelis MA (2001) Behavioral properties of the trigeminal somatosensory system in rats performing whisker- dependent tactile discriminations. J Neurosci 21: 5752–5763. 60. Mineur YS, Crusio WE (2002) Behavioral and neuroanatomical characteriza- tion of FVB/N inbred mice. Brain Res Bull 57: 41–47. 61. Wijnholds J, Evers R, van Leusden MR, Mol CA, Zaman GJ, et al. (1997) Increased sensitivity to anticancer drugs and decreased inflammatory response in ABC Transporters in Neurogenesis mice lacking the multidrug resistance-associated protein. Nat Med 3: 1275–1279. 62. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, et al. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491–502. 63. Schmidt A, Pahnke J (2012) Efficient near-infrared in vivo imaging of Aß deposits in Alzheimer’s disease mouse models. Jounal of Alzheimer’s Disease: in press. 64. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104–9110. 65. Charrier C, Coronas V, Fombonne J, Roger M, Jean A, et al. (2006) Characterization of neural stem cells in the dorsal vagal complex of adult rat by in vivo proliferation labeling and in vitro neurosphere assay. Neuroscience 138: 5–16. 66. Ferrari D, Binda E, De Filippis L, Vescovi AL (2010) Isolation of neural stem cells from neural tissues using the neurosphere technique. Curr Protoc Stem Cell Biol Chapter 2: Unit2D 6. 67. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408. 68. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, et al. (1995) Age- related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15: 1203–1218. 69. Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, et al. (2001) Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 891: 42–53. 70. Maldonado E, Navarro JF (2000) Effects of 3,4-methylenedioxy-methamphet- amine (MDMA) on anxiety in mice tested in the light-dark box. Prog Neuropsychopharmacol Biol Psychiatry 24: 463–472. PLoS ONE | www.plosone.org 14 April 2012 | Volume 7 | Issue 4 | e35613